Search

Biomass is currently the main energy source in Nigeria, but it is being used and managed unsustainably, resulting in significant health and environmental risks. To support Nigeria's transition to an affordable, reliable, and low‐emission future, there is a need to shift from traditional biomass use to modern bioenergy applications. The research reviews the existing knowledge on themes relevant to developing sustainable modern bioenergy for Nigeria in the context of agri‐residues. It synthesizes the key findings on the themes from 161 scientific literature published between 2010 and 2021 on Nigeria and Sub‐Saharan Africa. The findings show that most literature focused on agri‐residues potentially available in large amounts but highly disaggregated, such as cassava and palm residues. Furthermore, the literature highlighted the importance of understanding agri‐residue aggregation, technological, economic, socio‐economic, governance framework of bioenergy, and the interactions with other sectors to unlock the full potential of modern bioenergy. While research acknowledged that bioenergy could enhance energy security, economic growth, and social co‐benefits, there has been less focus on the benefits of novel bioenergy solutions co‐created by relevant stakeholder groups in Nigeria. Involving relevant stakeholders in developing novel bioenergy solutions would address the missing link between resource assessment, appropriate technology deployment, and end‐user demand. It would also enhance the analysis of the bioenergy market and nonmarket benefits and ensure that bioenergy solutions in Nigeria are aligned with community needs and foster inclusivity. This article is categorized under:Sustainable Energy > BioenergyPolicy and Economics > Governance and Regulation [ABSTRACT FROM AUTHOR]

Solar energy is one of the solutions to the global threats - climate change, environmental pollution, fossil fuel depletion and high cost of energy - associated with increased energy demand. In this research, the techno-economic feasibility and dynamic performance assessment of a smart solar Photovoltaic (PV) Direct Current grid (DC-grid) powered Separately Excited Direct Current Motor (SEDCM) is presented. The energy mapping was done at Agbani City (6°18.3′N, 7°33.8′E), in Enugu State, Nigeria. Agbani city was identified to have a good amount of solar energy with an annual average solar radiation of 4.67 kWh/m2/d. The dynamic performance assessment of a smart solar PV DC-grid powered SEDCM was conducted with the help of MATLAB/SIMULINK software. The result show that a change in sun intensity affects the photon-generated current and it has effect on the open-circuit voltage of the solar panel. This change in the intensity can be compensated for by the use of a boost converter. The whole system was optimized in HOMER Pro simulation software to assess the techno-economic feasibility of the system. From the techno-economic study, it was observed that the proposed DC-grid PV system is feasible for the generation of electricity to power the SEDCM. The cost of energy was calculated and the categorized result from HOMER Pro shows that the capacity of the DC-grid PV system (35.67 kW) with 120 Surrette S-260 batteries gives the cheapest configuration. This configuration has a cost of energy of 0.11 $/kWh and a Net Present Cost (NPC) value of 0.048 million dollars and was used as optimum system configuration. Comparing the system with the national grid, the proposed DC-grid PV configuration has a cost saving of 35% with 1.679 gCO2~eq/kWh greenhouse gas emission, while the national grid emits a significant amount of greenhouse gas up to 15,104 kg/y.

Objectives: To develop and assess the validity of a novel allergy‐specific domain for the 22‐item sino‐nasal outcomes test (SNOT‐22), to provide a new tool that efficiently quantifies the impact of allergic rhinitis (AR) concurrent with chronic rhinosinusitis. Study Design: Prospective validation study. Setting: Tertiary care hospital and community‐based clinic. Methods: Proposed items were developed based on clinician and patient input, and further assessed via factor analysis and for internal consistency (n = 1987). Items were then additionally assessed for convergent and discriminant validity (n = 415), applying data from concurrent completions of the Nasal Obstruction and Septoplasty Effectiveness Scale (NOSE), Mini‐Rhinoconjunctivitis Quality‐of‐Life Questionnaire (MiniRQLQ), and validated global health assessments. Assessments of intra‐rater reliability, responsiveness to change, and qualitative input were also performed. Results: Factor analysis demonstrated that proposed allergy items mapped to a single domain. Items were internally consistent (Cronbach α: 0.80 within domain, 0.91 within all SNOT). In assessments of convergent validity, domain scores were associated with MiniRQLQ (Spearman's ρ: 0.46, 95% confidence interval [CI]: 0.30‐0.59) and NOSE scores (0.36, 95% CI: 0.27‐0.44). The novel items also discriminated among clinical states: a 1‐point increase in domain score was associated with an 8.32 (95% CI: 5.43‐12.75) increase in the odds of prompting a visit for allergy‐related symptoms and a 1.52 (95% CI: 1.13‐2.05) increase in the odds of positive allergy testing. Intra‐rater reliability was substantial (Cohen's κ: 0.8, 95% CI: 0.8‐0.9), and responsiveness to change was demonstrated (mean difference: −0.6, 95% CI: −0.8 to −0.4). Conclusions: This novel domain is a valid, efficient measure of AR alongside rhinosinusitis. [ABSTRACT FROM AUTHOR]

Nigeria is purely an agrarian nation and the people depend on agriculture for survival. One of the missing links to wealth creation in Nigeria is lack of economic exploitation of abundant agricultural wastes. Instead of wealth creation, rice husk has become a serious threat to the environment. The unutilized rice husks in rice mills in Nigeria generate millions of tons of C02 when burnt. This increases environmental degradation and deaths associated with respiratory diseases. The sustainable use of this rice husk for bioenergy applications such as electricity generation at low cost, to mitigate greenhouse gas emissions is imperative. In this paper, an off-grid gasification power supply option for Adani, in Uzo-Uwani Local Government Area of Enugu state, of eastern Nigeria is presented. A detailed load assessment and availability of rice husk for power generation in the study area was conducted. This information was used to design the gasification system. The gasification system was designed based on the mass flow rate of producer gas required to power the gas engine at full load. The gasifier was designed downdraft with air and steam as the oxidizing agent, in order to maintain uniform temperature in the oxidation and reduction zones. Furthermore, techno-economic analysis approach was used to determine the economic viability of the designed power system considered in this study. The estimated total load demand of the study area is 850.054kW. The estimated total daily, monthly and yearly energy demands of the study area are: 8,991 ​kWh, 269,736.42 ​kWh and 3,236,837.04 ​kWh. The annual availability of rice husk in the study area is 3,636t/y and it has potential of 1.52MW power generation with daily, monthly and yearly energy generation of: 36.48 ​MWh, 1,094.4 ​MWh and 13,132.8 ​MWh. This potential of electricity generation has power station capacity of 1.9 MVA, which is approximately equal to 2 MVA. The Levelized Cost of Electricity of the designed power system is 3.6 Naira/kWh, which is cheaper than 30.93 Naira/kWh tariff bill by Enugu Electricity Distribution Company to its R2S customers. Based on the proposed rice husk gasification system, a community could generate power to meet their electricity demand in most economical way, thereby reducing emission, waste and saving cost translating to sustainable development.

The shift to renewable energy sources is essential for mitigating climate change, but it poses fresh challenges for environmentally responsible waste management. This article reviews and investigates the complex problems associated with the disposal of renewable energy components from an environmental, social, and governance (ESG) perspective. The article further highlights the need for thorough oversight and careful management of various components due to the environmental concerns associated with their disposal as they frequently contain hazardous elements. The social effects on communities impacted by disposal procedures are also explored, and the importance of fair distribution of benefits is emphasized. Transparency, accountability, and stakeholder involvement are bolstered by effective governance, which is a central theme of this discussion that draws on ESG concepts. Successful ESG-integrated disposal plans are demonstrated by industry case studies. Possible hindrances in sustainable disposal are also highlighted with firm suggestions on way-forward, which include technical innovation and global collaboration. The study underlines the irreplaceable role played by ESG in guiding responsible waste management toward a sustainable, green energy future. [ABSTRACT FROM AUTHOR]

Objective: While general health may be influenced by sinonasal symptoms, their effects may be overshadowed by comorbid states which may be more serious. To assess the validity of this postulate, we measured the extent to which sinonasal symptoms and concurrent conditions influenced general health. Study Design: Observational outcomes study. Setting: Academic medical center, community care sites. Methods: Adults with sinonasal symptoms completed the 22‐item Sinonasal Outcome Test, along with the Patient‐Reported Outcomes Measurement Information System global health short form. Comorbidities were categorized with the Deyo modification of the Charlson comorbidity index. Multivariate regression analyses were utilized to determine the relative impact of sinonasal symptoms and concurrent comorbid conditions on general health. Results: Data from 219 consecutive patients demonstrated that sinonasal symptoms were associated with significantly diminished general physical (β = −1.431, p <.001), mental (β = −1.000, p <.001), overall (β = −1.026, p <.001), and social health (β = −0.872, p =.003), regardless of the presence of potentially life‐threatening comorbid conditions. Comorbid conditions included cardiovascular disease, chronic obstructive pulmonary disease, connective tissue disease, peptic ulcer, diabetes mellitus, and hepatic disease. The effect of sinonasal symptoms was neither subsumed nor overshadowed by the effects of comorbid states. Nasal, ear, sleep, and psychological domain scores were also associated with general physical, mental, and global health while adjusting for the impact of comorbidities. Conclusion: Sinonasal symptoms have a substantial effect on general health which is not subsumed by the presence of potentially life‐threatening concurrent comorbidities. These data may help support the importance of funding and resource allocation for conditions causing sinonasal symptoms. [ABSTRACT FROM AUTHOR]

Objective: The overall discriminatory ability of validated instrument scores for computed tomography (CT) findings of chronic rhinosinusitis has limitations and may be modified by multiple factors. To support optimal methods for assessment, we studied which factors could influence this relationship, including the concurrent impact of multiple discrete CT scoring mechanisms, colocalized imaging findings, and nasal comorbid conditions. Study Design: Observational outcomes study. Setting: Academic medical center. Methods: Patients with sinonasal complaints who completed the 22-item Sinonasal Outcome Test (SNOT-22) and underwent CT were included. Multivariate ordinal regression was utilized to assess associations. CT data were quantified with the Lund-Mackay system, Zinreich system, and a direct measure of maximal mucosal thickness. The impact of incidental findings (mucous retention cysts, periapical dental disease) and nasal comorbid conditions was also assessed. Results: A total of 233 patients were included. SNOT-22 nasal scores were significantly associated with CT results when those with incidental findings were excluded, regardless of the radiologic scoring mechanism utilized: Lund-Mackay regression coefficient, 0.321 (P =.046); Zinreich, 0.340 (P =.033); and maximum mucosal thickness, 0.316 (P =.040). This relationship subsided when incidental findings were present. SNOT-22 overall scores, sleep scores, and psychological domain scores had no significant association with imaging results, regardless of radiologic scoring system utilized. Nasal comorbid conditions had inconsistent associations. Conclusions: SNOT-22 nasal domain scores were associated with all 3 radiologic scoring systems when incidental findings were absent but not when they were present. Delineating the presence or absence of these colocalized findings affected the relationship between SNOT-22 scores and radiological results, beyond other concurrent factors. [ABSTRACT FROM AUTHOR]

Objective: The 22-item Sinonasal Outcome Test (SNOT-22) is a trusted measure of symptom severity in chronic rhinosinusitis. The European Position Paper on Rhinosinusitis (EPOS) provides widely accepted diagnostic criteria, which include sinonasal symptoms, their duration, and imaging results. Our objective was to compare these approaches to assessing symptoms to determine if either was more indicative of radiologic findings, to support decisions in telehealth. Study Design: Observational outcomes study. Setting: Tertiary care center. Methods: In total, 162 consecutive patients provided a structured sinonasal history, completed the SNOT-22, and underwent sinus computed tomography (CT) within 1 month. SNOT-22 scores, EPOS-defined symptom sets, and Lund-Mackay results were assessed. To facilitate direct comparisons, we performed stepwise evaluations of sinonasal symptoms alone and combined with duration. The discriminatory capacity for imaging results was determined through areas under the receiver operating characteristic curves (ROC-AUC) for dichotomous outcomes and ordinal regression for multilevel outcomes. Results: In ROC-AUC analyses, SNOT-22 and EPOS-defined symptoms had similar discriminatory capacity for Lund-Mackay scores, regardless of duration. Within ordinal regression analyses, SNOT-22 nasal scores were significantly associated with Lund-Mackay scores, while EPOS-defined nasal symptoms were not statistically significantly related. Conclusions: SNOT-22 nasal scores and EPOS-defined nasal symptoms may have similar associations with imaging results when assessed via ROC-AUC, while SNOT-22 may have more association within ordinal data. Understanding the implications of discrete patterns of symptoms may confer benefit, particularly when in-person and fiberoptic exams are limited. [ABSTRACT FROM AUTHOR]

Objectives/hypothesis: Institutional and national programs have endorsed the use of validated instruments in daily practice, but their utility for frontline clinicians is unknown. Our first objective was thus to determine if routinely obtained patient descriptions accurately predict disease-specific validated instrument results. Our second objective was to assess the feasibility of deploying an electronic system to obtain and document patient-reported descriptions of health status.Study Design: Prospective assessment of consecutive eligible ambulatory care patients.Methods: For the first objective, patients presenting with the same chief complaint at consecutive visits provided concurrent routine symptom descriptions and validated instrument responses. To determine whether patients' routine descriptions predicted scores from disease-specific instruments, receiver operator characteristic (ROC) curves, sensitivity/specificity, Spearman ρ correlation, and regression models were utilized. For the second objective, feasibility assessment focused on percent with successful response capture, time to questionnaire completion, and impact on physician time needed to obtain and document patient histories.Results: For the first objective, among patients with hearing loss, eustachian tube dysfunction, nasal obstruction, and chronic rhinosinusitis, the areas under the ROC curves were 0.38 to 0.83. Spearman ρ coefficients were 0.25 to 0.46. Sensitivity and specificity ranged from 15.9% to 87.8%, with correct classification in 42.3% to 55.2% of cases. For the second objective, there was a 91% completion rate. Completion times were 7:18 to 12:37 for new patients and 3:23 to 6:41 for established patients. Physician time savings were estimated at 11 minutes per patient.Conclusions: Using validated instruments and electronic data collection systems in daily practice has practical and clinical implications. These topics warrant further study.Level Of Evidence: 2c Laryngoscope, 130:S1-S13, 2020. [ABSTRACT FROM AUTHOR]

Objectives: To investigate the potential association of macrolide antibiotics with sensorineural hearing loss (SNHL) and which agents and dosage may be related. To evaluate whether an optimal treatment exists for reversing SNHL that occurs after macrolide therapy.Study Design: Systematic review of the literature.Methods: Computerized (PubMed, EMBASE, Cochrane Library) and manual searches were performed to identify human studies of all ages (patients) who received macrolides (intervention, with or without control) and documented SNHL (outcome). All study designs were assessed. Extracted data included macrolide regimen details, as well as the timing, severity, and reversibility of SNHL with drug cessation alone or with additional medical intervention. Study designs and the associated risk of bias were assessed.Results: The 44 publications (3 prospective, 41 retrospective) that met these criteria described 78 cases of audiometrically confirmed SNHL. SNHL was associated with oral and intravenous macrolide administration at standard and elevated doses. SNHL was irreversible in six cases, despite macrolide cessation (n = 5) and oral steroid treatment (n = 1). Irreversible SNHL was observed following 2 to 3 days of exposure. SNHL was reversible with macrolide cessation alone in 70 cases. In two cases, macrolide cessation coupled with oral steroid administration restored hearing. Reversible cases improved within hours to days. Nine studies also described 42 cases of subjective patient-reported hearing loss. Limitations in the data arose from study design, related comorbidities, and concomitant drug administration.Conclusion: SNHL may follow macrolide exposure, even at standard oral doses. Further research is needed to understand the incidence, prevalence, and biological mechanism of its ototoxicity. Laryngoscope, 128:228-236, 2018. [ABSTRACT FROM AUTHOR]